Last reviewed · How we verify
Placebo Folic Acid — Competitive Intelligence Brief
marketed
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo Folic Acid (Placebo Folic Acid) — National Heart, Lung, and Blood Institute (NHLBI). Placebo folic acid has no active pharmacological mechanism; it serves as an inert control in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo Folic Acid TARGET | Placebo Folic Acid | National Heart, Lung, and Blood Institute (NHLBI) | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo Folic Acid CI watch — RSS
- Placebo Folic Acid CI watch — Atom
- Placebo Folic Acid CI watch — JSON
- Placebo Folic Acid alone — RSS
Cite this brief
Drug Landscape (2026). Placebo Folic Acid — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-folic-acid. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab